Nomura Holdings
NTLA icon

Nomura Holdings’s Intellia Therapeutics NTLA Stock Holding History

Nomura Holdings’s Portfolio NTLA Stock Details NTLA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-10,995
Closed -$98.8K – 1994
2025
Q4 		$98.8K Sell
10,995
-30,010
-73% -$413K ﹤0.01% 1835
2025
Q3 		$708K Buy
+41,005
New +$505K ﹤0.01% 1506
2024
Q2 		– Sell
-7,740
Closed -$213K – 1947
2024
Q1 		$213K Buy
+7,740
New +$215K ﹤0.01% 1448
2023
Q3 		– Sell
-185,033
Closed -$7.55M – 1562
2023
Q2 		$7.55M Sell
185,033
-185,555
-50% -$7.52M 0.02% 401
2023
Q1 		$13.8M Sell
370,588
-198,364
-35% -$7.78M 0.04% 277
2022
Q4 		$19.8M Buy
568,952
+399,175
+235% +$19M 0.08% 183
2022
Q3 		$9.52M Buy
+169,777
New +$10.5M 0.04% 362
2021
Q3 		– Sell
-2,800
Closed -$453K – 2139
2021
Q2 		$453K Sell
2,800
-481,816
-99% -$37.5M ﹤0.01% 1400
2021
Q1 		$38.9M Buy
+484,616
New +$32.5M 0.09% 125
2020
Q4 		– Sell
-10,440
Closed -$210K – 1617
2020
Q3 		$210K Sell
10,440
-123,260
-92% -$2.57M ﹤0.01% 1178
2020
Q2 		$2.81M Buy
+133,700
New +$2.27M 0.01% 496

Other funds holding NTLA

AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
RP
Regeneron Pharmaceuticals Tarrytown, New York $47.9M AUM 29.29% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Nomura Holdings's NTLA Position: Q1 2026 in Review

Nomura Holdings sold out of Intellia Therapeutics (NTLA) in Q1 2026, closing a stake of 10,995 shares — an estimated $98.8K sold.

Nomura Holdings first reported a position in NTLA in Q2 2020 and held it in 11 quarters. The position peaked at $38.9M in Q1 2021. 302 funds tracked by Wall St. Rank hold NTLA as of Q1 2026.

  • Nomura Holdings reported no remaining Intellia Therapeutics position as of Q1 2026 after selling out during the quarter.
  • Nomura Holdings sold 10,995 Intellia Therapeutics shares in Q1 2026, an estimated $98.8K.
  • Nomura Holdings first reported a position in Intellia Therapeutics in Q2 2020 and held it in 11 quarters.
  • Nomura Holdings's Intellia Therapeutics position peaked at $38.9M in Q1 2021.
  • 302 funds tracked by Wall St. Rank held Intellia Therapeutics as of Q1 2026.

Based on Nomura Holdings's 13F filing for Q1 2026, filed 15 May 2026.